Clinical Trial Update: Prehospital Kcentra for Hemorrhagic Shock [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for prehospital administration of Kcentra in hemorrhagic shock due to trauma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trauma Injury
• Traumatic Hemorrhagic Shock

Drugs mentioned

• KCENTRA

Snippet

Sponsor: Oregon Health and Science University | Conditions: Trauma Injury | Phase 2 | Status: UNKNOWN